New Swiss devices law aligns with EU, adds country-specific provisions
This article was originally published in RAJ Devices
The Swiss government has aligned its national laws with the European Union’s amending medical devices legislation (Directive 2007/47/EC) and has also introduced some country-specific measures, all of which enter into force on 1 April1,2.
You may also be interested in...
Based on the operational experience gained using the new international standard for reporting suspected adverse reactions in EudraVigilance, the EU has decided to set a date for its mandatory use.
The UK’s Health Research Authority has agreed in principle to implement a new policy that aims to drive a lasting change in clinical trial transparency. Not everyone is convinced.
The UK scheme allows patients with early access to promising new unlicensed medicines when there is a clear unmet medical need.